Letrozole: future alternative to methotrexate for treatment of ectopic pregnancy?


Like Comment
Related Content

VOLUME 114, ISSUE 2, P273-274


Nathalie Auger, M.D., M.Sc., Aimina Ayoub, M.Sc., Shu Qin Wei, M.D., Ph.D.


Reflections on "The aromatase inhibitor, letrozole: a novel treatment for ectopic pregnancy" by Mitwally et al.

Read the full text here. 

Fertility and Sterility

Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders. The journal publishes juried original scientific articles in clinical and laboratory research relevant to reproductive endocrinology, urology, andrology, physiology, immunology, genetics, contraception, and menopause. Fertility and Sterility® encourages and supports meaningful basic and clinical research, and facilitates and promotes excellence in professional education, in the field of reproductive medicine.